Phage therapy program
NYU Langone NTM/bronchiectasis phage program
| Status | Intake unconfirmed |
|---|---|
| Type | Center |
| Location | New York, New York; United States |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | Institutional account describes treatment for selected patients in its NTM program. Recruiting observational biomarker study NCT07076238 lists research contacts; it does not itself provide therapeutic access. |
|---|---|
| Areas of work | Selected severe NTM infection with bronchiectasis treated under individualized IND; collaboration with Pittsburgh for matching. Biomarker study also covers other infections. |
| International access | No public international-patient eligibility or acceptance policy verified. |
What to confirm
- NCT07076238 is NYU-sponsored and observational, not a UCSD therapeutic trial. Open outside-patient phage intake and acceptance criteria unverified.
Related studies(1)
Biomarkers of Phage Treatment Response in NTM and Other Infections
Recruiting
Recorded program–study link. Website
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
- Advancing Phage Therapy for Nontuberculosis Mycobacteria Infection and Bronchiectasis
- NCT07076238 — ClinicalTrials.gov
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | nyu-phage |
|---|